504 related articles for article (PubMed ID: 32698732)
21. SARS-CoV-2 Infection Leads to Neurological Dysfunction.
Acharya A; Kevadiya BD; Gendelman HE; Byrareddy SN
J Neuroimmune Pharmacol; 2020 Jun; 15(2):167-173. PubMed ID: 32447746
[TBL] [Abstract][Full Text] [Related]
22. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
Iroegbu JD; Ifenatuoha CW; Ijomone OM
Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
[TBL] [Abstract][Full Text] [Related]
23. Neurological complications of COVID-19: from bridesmaid to bride.
Nath A; Smith B
Arq Neuropsiquiatr; 2020 Sep; 78(8):459-460. PubMed ID: 32901698
[No Abstract] [Full Text] [Related]
24. [COVID-19: A neurological point-of-view].
Simon OJ; Timmermann L
Dtsch Med Wochenschr; 2020 Jul; 145(15):1074-1079. PubMed ID: 32731282
[TBL] [Abstract][Full Text] [Related]
25. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions.
Favas TT; Dev P; Chaurasia RN; Chakravarty K; Mishra R; Joshi D; Mishra VN; Kumar A; Singh VK; Pandey M; Pathak A
Neurol Sci; 2020 Dec; 41(12):3437-3470. PubMed ID: 33089477
[TBL] [Abstract][Full Text] [Related]
26. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
27. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection.
Coen M; Jeanson G; Culebras Almeida LA; Hübers A; Stierlin F; Najjar I; Ongaro M; Moulin K; Makrygianni M; Leemann B; Kronig I; Bertrand J; Reny JL; Schibler M; Serratrice J
Brain Behav Immun; 2020 Jul; 87():111-112. PubMed ID: 32360440
[No Abstract] [Full Text] [Related]
28. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
Juliao Caamaño DS; Alonso Beato R
J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
[TBL] [Abstract][Full Text] [Related]
29. Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity.
Grijalva-Otero I
Gac Med Mex; 2020; 156(4):339-343. PubMed ID: 32831327
[TBL] [Abstract][Full Text] [Related]
30. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke.
Al Saiegh F; Ghosh R; Leibold A; Avery MB; Schmidt RF; Theofanis T; Mouchtouris N; Philipp L; Peiper SC; Wang ZX; Rincon F; Tjoumakaris SI; Jabbour P; Rosenwasser RH; Gooch MR
J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):846-848. PubMed ID: 32354770
[TBL] [Abstract][Full Text] [Related]
31. Neurotropism of SARS-CoV 2: Mechanisms and manifestations.
Conde Cardona G; Quintana Pájaro LD; Quintero Marzola ID; Ramos Villegas Y; Moscote Salazar LR
J Neurol Sci; 2020 May; 412():116824. PubMed ID: 32299010
[No Abstract] [Full Text] [Related]
32. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.
Zayet S; Klopfenstein T; Kovẚcs R; Stancescu S; Hagenkötter B
Emerg Infect Dis; 2020 Sep; 26(9):2258-60. PubMed ID: 32453685
[TBL] [Abstract][Full Text] [Related]
33. Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.
Patel SD; Kollar R; Troy P; Song X; Khaled M; Parra A; Pervez M
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105231. PubMed ID: 33066910
[TBL] [Abstract][Full Text] [Related]
34. The neurological impact of COVID-19.
The Lancet Neurology
Lancet Neurol; 2020 Jun; 19(6):471. PubMed ID: 32470408
[No Abstract] [Full Text] [Related]
35. Neurological Manifestations of COVID-19: A systematic review and current update.
Whittaker A; Anson M; Harky A
Acta Neurol Scand; 2020 Jul; 142(1):14-22. PubMed ID: 32412088
[TBL] [Abstract][Full Text] [Related]
36. Neurological manifestations of coronavirus infections - a systematic review.
Almqvist J; Granberg T; Tzortzakakis A; Klironomos S; Kollia E; Öhberg C; Martin R; Piehl F; Ouellette R; Ineichen BV
Ann Clin Transl Neurol; 2020 Oct; 7(10):2057-2071. PubMed ID: 32853453
[TBL] [Abstract][Full Text] [Related]
37. Demographic characteristics and neurological comorbidity of patients with COVID-19.
Acar T; Acar BA; Aras YG; Doğan T; Boncuk S; Eryılmaz HA; Can N; Can Y
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):82-85. PubMed ID: 32965362
[TBL] [Abstract][Full Text] [Related]
38. Impact of COVID-19 pandemic on subarachnoid hemorrhage.
Bernat AL; Giammattei L; Abbritti R; Froelich S
J Neurosurg Sci; 2020 Aug; 64(4):409-410. PubMed ID: 32347681
[No Abstract] [Full Text] [Related]
39. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
Bereczki D; Stang R; Böjti P; Kovács T
Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
[TBL] [Abstract][Full Text] [Related]
40. Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms.
Mohammadi S; Moosaie F; Aarabi MH
Mol Neurobiol; 2020 Dec; 57(12):5263-5275. PubMed ID: 32869183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
